Any thoughts on investing in the needle-free vaccine delivery? How much does this news help these three companies?
If you want to participate to a material degree in the upside from this technology, you can’t do it by owning GSK or NVS. You have to buy Intercell, which trades on the Vienna exchange.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”